日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Age on Patient-Reported Outcomes with First-Line Camrelizumab plus Rivoceranib versus Sorafenib in Adults with Unresectable Hepatocellular Carcinoma: Post Hoc Analyses of the CARES-310 Open-Label, Randomized, Phase 3 Trial

年龄对不可切除肝细胞癌成人患者一线卡瑞利珠单抗联合利沃西拉尼与索拉非尼单药治疗患者报告结局的影响:CARES-310开放标签、随机、3期试验的事后分析

Chan, Stephen Lam; Kaseb, Ahmed Omar; Alexander, Laura; Meng, Xianzhang; Ryan, Kristin; Shi, Wei; Vogel, Arndt

Navigating second-line therapy after immunotherapy in advanced HCC☆

晚期肝细胞癌免疫治疗后二线治疗的策略☆

Vogel, Arndt; Saborowski, Anna; Rimassa, Lorenza; El-Khoueiry, Anthony

Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study

胆道癌生物标志物检测的临床实践及意义:一项观察性研究

Welland, Sabrina; Zöller, Ann-Kristin; Mavroeidi, Ilektra A; Tomczak, Aurelie; Müller, Christian; Yawen, Dong; Zhang, Danmei; Keil, Felix; Pangerl, Maria; Zhou, Taotao; Taghizadeh, Hossein; Lange, Sebastian; Kinzler, Maximilian N; Shmanko, Kataryna; Barsch, Maryam; Zimpel, Carolin; Djanani, Angela; Schulze-Bergkamen, Henning; Keyl, Julius; Lüke, Florian; Wirth, Thomas; Dill, Michael; Longerich, Thomas; Petschnak, Sophia; Marquardt, Jens U; Quante, Michael; Weinmann, Arndt; Walter, Dirk; Pfarr, Nicole; Prager, Gerald; Doleschal, Bernhard; Gonzalez-Carmona, Maria A; Günther, Rainer; Scheiter, Alexander; Böck, Stefan; Bartels, Stephan; Gruenberger, Thomas; Venerito, Marino; Springfeld, Christoph; Kasper, Stefan; Saborowski, Anna; Vogel, Arndt

Liver transplantation for HCC with macrovascular invasion: A systematic review and meta-analysis of observational studies

肝细胞癌伴大血管侵犯的肝移植:观察性研究的系统评价和荟萃分析

Ladak, Farah; Josef Magyar, Christian Tibor; Gaviria, Felipe D; Choi, Woo Jin; Zorigtbaatar, Anudari; Bucur, Roxana; Rukavina, Nadia; Vogel, Arndt; O'Kane, Grainne Mary; Li, Zhihao; Englesakis, Marina; Sapisochin, Gonzalo

Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction-Associated Steatohepatitis Patients

肝脏CD4 T细胞可预测代谢功能障碍相关脂肪性肝炎患者的肝细胞癌风险

Rodriguez, Emilse; Simon, Peter; Dhooge, Sabrina; Fernandez, Marina; Calafat, Patricia; Kurpis, María; Nuñez, Nicolás; Prieto, Jhon; Saborowski, Anna; Vogel, Arndt; Debes, José Daniel; Balderramo, Domingo Cesar; Boonstra, Andre; Romagnoli, Pablo Alberto

Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

影像学在肝细胞癌局部和区域治疗的分期、治疗计划制定和监测中的应用:EORTC 和 ESGAR 的共识建议

Öcal, Osman; Zech, Christoph Johannes; Bali, Maria Antonietta; Pasquier, David; Mottaghy, Felix; Einspieler, Ingo; Kartalis, Nikolaos; Bargellini, Irene; Iezzi, Roberto; Denecke, Timm; Kunz, Wolfgang Gerhard; Gebauer, Bernhard; Wege, Henning; Cannella, Roberto; Oprea-Lager, Daniela Elena; Vogel, Arndt; Sangro, Bruno; Seidensticker, Max

Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

更正:肝细胞癌局部和区域治疗的分期、治疗计划和监测中的影像学应用:EORTC 和 ESGAR 的共识建议

Öcal, Osman; Zech, Christoph Johannes; Bali, Maria Antonietta; Pasquier, David; Mottaghy, Felix; Einspieler, Ingo; Kartalis, Nikolaos; Bargellini, Irene; Iezzi, Roberto; Denecke, Timm; Kunz, Wolfgang Gerhard; Gebauer, Bernhard; Wege, Henning; Cannella, Roberto; Oprea-Lager, Daniela Elena; Vogel, Arndt; Sangro, Bruno; Seidensticker, Max

Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study

KEYNOTE-966研究中乙型肝炎病毒感染对帕博利珠单抗联合化疗治疗晚期胆道癌疗效和安全性的影响

Chan, Stephen L; Yau, Thomas; Kelley, Robin K; Finn, Richard S; Yoo, Changhoon; Furuse, Junji; Ren, Zhenggang; Klümpen, Heinz-Josef; Ozaka, Masato; Pelzer, Uwe; Arslan, Cagatay; Park, Joon Oh; Edeline, Julien; Valle, Juan W; Ueno, Makoto; Vogel, Arndt; Starkopf, Liis; Malhotra, Usha; Siegel, Abby B; Qin, Shukui

BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of (225)Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular Carcinoma

BANTAM-01:一项多中心、开放标签、首次人体I期剂量递增和扩展研究,旨在评估(225)Ac-GPC3 (BAY 3547926)在晚期肝细胞癌患者中的疗效

Tjeertes, Jorrit; Dostalek, Miroslav; Glaus, Charles; Gupta, Vinita; Li, Daneng; Nestler, Antje; Pelekanou, Vasiliki; Pinkert, Joerg; Ratih, Ida; Smith, Eric; Subramanyam, Shyamal; Vogel, Arndt; Walker, Katrina; Wilson Woods, Andrea; Zimmermann, Stefan; Junger, Henrik

Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]

对“晚期胆道癌的新系统治疗模式及欧洲患者就医机会的差异”一文的更正[《柳叶刀区域健康 - 欧洲》,第 50 卷,2025 年 3 月,101170]

Rimassa, Lorenza; Lamarca, Angela; O'Kane, Grainne M; Edeline, Julien; McNamara, Mairéad G; Vogel, Arndt; Fassan, Matteo; Forner, Alejandro; Kendall, Timothy; Adeva, Jorge; Casadei-Gardini, Andrea; Fornaro, Lorenzo; Hollebecque, Antoine; Lowery, Maeve A; Macarulla, Teresa; Malka, David; Mariamidze, Elene; Niger, Monica; Ustav, Anu; Bridgewater, John; Macias, Rocio I R; Braconi, Chiara